As the saying goes.... success breeds success. The indicative results on the first 5 patients seems positive and hopefully is being leveraged to achieve faster recruitment. Good to see the share price moving up somewhat on decent volume. Strong conviction buying is still not here yet, but more to the point, conviction selling at the recent capitulation prices seems to have abated.
